Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Aldeyra Therapeutics
ALDX
$97.1M
| $3.67M | ﹤0.01% |
735,763
+131,722
| +22% | +$676K |
|
2627
Summit Therapeutics
SMMT
$10.2B
| $3.66M | ﹤0.01% |
205,337
+160,592
| +359% | +$3.11M |
|
2628
CS Disco
LAW
$271M
| $3.63M | ﹤0.01% |
727,192
+41,631
| +6% | +$242K |
|
|
YMAB
2629
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.63M | ﹤0.01% |
463,235
-14,429
| -3% | -$176K |
|
2630
Shoals Technologies Group
SHLS
$1.33B
| $3.62M | ﹤0.01% |
654,753
-8,170
| -1% | -$41.5K |
|
2631
Five Point Holdings
FPH
$387M
| $3.58M | ﹤0.01% |
947,949
+198,103
| +26% | +$776K |
|
2632
Holley
HLLY
$335M
| $3.56M | ﹤0.01% |
1,180,045
+104,071
| +10% | +$292K |
|
2633
Mastech Digital
MHH
$95.4M
| $3.56M | ﹤0.01% |
238,705
+3,922
| +2% | +$48.8K |
|
|
IVAC
2634
DELISTED
Intevac Inc
IVAC
| $3.56M | ﹤0.01% |
1,045,648
-16,789
| -2% | -$53K |
|
2635
Globalstar
GSAT
$10.1B
| $3.52M | ﹤0.01% |
113,130
+100,714
| +811% | +$2.49M |
|
2636
Harvard Bioscience
HBIO
$27.6M
| $3.51M | ﹤0.01% |
166,511
-5,077
| -3% | -$117K |
|
|
BPMC
2637
DELISTED
Blueprint Medicines
BPMC
| $3.51M | ﹤0.01% |
40,208
+1,200
| +3% | +$110K |
|
|
EWCZ
2638
DELISTED
European Wax Center
EWCZ
| $3.49M | ﹤0.01% |
523,342
-13,347
| -2% | -$87.8K |
|
2639
Marathon Digital Holdings
MARA
$3.83B
| $3.49M | ﹤0.01% |
207,839
+3,998
| +2% | +$80.9K |
|
2640
MoonLake Immunotherapeutics
MLTX
$1.56B
| $3.49M | ﹤0.01% |
+64,384
| New | +$3.29M |
|
|
AC
2641
DELISTED
Associated Capital Group
AC
| $3.48M | ﹤0.01% |
101,610
-488
| -0.5% | -$17.8K |
|
2642
Cato Corp
CATO
$65.7M
| $3.47M | ﹤0.01% |
889,620
-36,565
| -4% | -$178K |
|
2643
First Northwest Bancorp
FNWB
$114M
| $3.46M | ﹤0.01% |
339,408
-8,775
| -3% | -$92.6K |
|
|
AGS
2644
DELISTED
PlayAGS
AGS
| $3.45M | ﹤0.01% |
299,524
| – | – |
|
2645
SB Financial Group
SBFG
$163M
| $3.45M | ﹤0.01% |
164,832
+5,137
| +3% | +$105K |
|
2646
Chegg
CHGG
$116M
| $3.44M | ﹤0.01% |
2,138,524
-1,302,151
| -38% | -$2.4M |
|
2647
Comtech Telecommunications
CMTL
$49.7M
| $3.43M | ﹤0.01% |
855,662
-7,315
| -0.8% | -$26.1K |
|
2648
Arq
ARQ
$83.3M
| $3.4M | ﹤0.01% |
449,312
+177,550
| +65% | +$1.17M |
|
2649
Montauk Renewables
MNTK
$253M
| $3.39M | ﹤0.01% |
851,345
+46,558
| +6% | +$223K |
|
2650
ZipRecruiter
ZIP
$339M
| $3.39M | ﹤0.01% |
467,831
+42,116
| +10% | +$377K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.